Eagle Pharmaceuticals, Inc. (EGRX)
NASDAQ: EGRX · IEX Real-Time Price · USD
4.550
-0.060 (-1.30%)
At close: Apr 22, 2024, 4:00 PM
4.560
+0.010 (0.22%)
After-hours: Apr 22, 2024, 4:51 PM EDT
Eagle Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for EGRX stock has a target of 17, which predicts an increase of 273.63% from the current stock price of 4.55.
Analyst Consensus: Sell
* Price targets were last updated on Aug 9, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for EGRX is "Sell". This means that the analyst believes this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold → Sell Downgrades $26 → $17 | Hold → Sell | Downgrades | $26 → $17 | +273.63% | Aug 9, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Mar 2, 2020 |
| Mizuho | Mizuho | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Mar 22, 2019 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 31, 2018 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 21, 2018 |
Financial Forecast
Revenue This Year
263.51M
from 316.61M
Decreased by -16.77%
Revenue Next Year
215.73M
from 263.51M
Decreased by -18.13%
EPS This Year
4.67
from 2.73
Increased by 71.12%
EPS Next Year
3.34
from 4.67
Decreased by -28.60%
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | 271.3M | 222.1M | 235.2M |
| Avg | 263.5M | 215.7M | 228.5M |
| Low | 253.2M | 207.3M | 219.5M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | -14.3% | -15.7% | 9.0% |
| Avg | -16.8% | -18.1% | 5.9% |
| Low | -20.0% | -21.3% | 1.8% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | 4.81 | 3.43 | 3.14 |
| Avg | 4.67 | 3.34 | 3.05 |
| Low | 4.49 | 3.20 | 2.93 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | 76.2% | -26.5% | -5.9% |
| Avg | 71.1% | -28.6% | -8.6% |
| Low | 64.4% | -31.4% | -12.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.